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1 |  INTRODUCTION
Warsaw Breakage Syndrome (WABS; OMIM #613398) is 
an ultra rare genetic disease caused by biallelic mutations of 
the DDX11 (DEAD/H box‐11) gene. DDX11 (also named 
Ch1R1) belongs to Rad3/XPD FeS helicase family, whose 
members unwind DNA with a 5′ to 3′ directionality(Bharti 
et al., 2014). Sharing sequence similarity with FANCJ, XPD, 
and RTEL‐1 helicases, DDX11 is involved in the mainte-
nance of genomic stability and cohesion of sister chroma-
tids(Sun et al., 2015). WABS is characterized by prenatal and 
postnatal growth delay with microcephaly, various degrees 
of intellectual disability, hearing loss with cochlear malfor-
mation, and skin pigmentation abnormalities. Dysmorphic 
features include sloping forehead and narrow bifrontal diam-
eter, prominent eyes, upslanting palpebral fissures, epican-
thus, hypoplastic alae nasi, and small mouth (Alkhunaizi et 
al., 2018; Bailey, Fryer, & Greenslade, 2015; Capo‐Chichi et 
al., 2013; Eppley, Hopkin, Mendelsohn, & Slavotinek, 2017; 
van der Lelij et al., 2010). Patients might also present hy-
potonia, cardiac malformations, and bone (radial and fibula) 
malformations.
Cells from WABS patients show an increase in spontaneous 
and mitomycin C (MMC)‐induced chromosomal breakage and 
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Abstract
Background: Warsaw Breakage Syndrome (WABS) is an ultra rare cohesinopathy 
caused by biallelic mutation of DDX11 gene. It is clinically characterized by pre and 
postnatal growth delay, microcephaly, hearing loss with cochlear hypoplasia, skin 
color abnormalities, and dysmorphisms.
Methods: Mutational screening and functional analyses (protein expression and 3D‐
modeling) were performed in order to investigate the presence and pathogenicity of 
DDX11 variant identified in our patients.
Results: We report the clinical history of two sisters affected by WABS with a path-
ological mytomicin C test carrying compound heterozygous mutations (c.2507T > C 
/ c.907_920del) of the DDX11 gene. The pathogenicity of this variant was confirmed 
in the light of a bioinformatic study and protein three‐dimensional modeling, as well 
as expression analysis.
Conclusion: These findings further extend the clinical and molecular knowledge 
about the WABS showing a possible mild phenotype without major malformations 
or intellectual disability.
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sister chromatid cohesion defects with a typical railroad chro-
mosome structures, showing cytogenetic overlap with Fanconi 
anemia (FA) and Roberts breakage syndrome (RBS) (Capo‐
Chichi et al., 2013; van der Lelij et al., 2010). Herein, we report 
the clinical history of two sisters with WABS, who are com-
pound heterozygous for two novel mutations of DDX11.
2 |  MATERIALS AND METHODS
2.1 | DNA sequencing
Written informed consent was obtained from patients or from 
relatives/guardians whenever applicable. All experiments 
were carried out in accordance with the approved guidelines. 
Genomic DNA was extracted from peripheral blood of both pa-
tients and parents. Sanger sequencing was performed in order 
to confirm mutation and for segregation study, as previously 
described. Primers used for the amplification are available upon 
request. PCR products were bidirectionally sequenced using an 
ABI 3100 automated sequencer (Applied Biosystem).
2.2 | Cell culture and mitomycin C 
survival assay
Patient's and wild type lymphoblast cell lines (LFB) were 
generated from primary lymphocytes isolated from periph-
eral blood as described in Ravera et al. (2016). Cells were 
grown at 37°C in RPMI supplemented with 10% FBS and 
antibiotics. Mytomycin C (MMC) survival assay were per-
formed using a standard method. Briefly, lymphoblast cells 
were collected and exposed to increasing concentrations of 
MMC (0–333 nmol/L) for 5 days. Then, cells were resus-
pended in PBS plus 0.05% BSA and 0.5 μg/ml propidium 
iodide for 10 min at 4°C. Cell viability was analyzed by flow 
cytometry.
2.3 | Protein expression analyses
Fractionated (nucleus/cytoplasm) and not‐fractionated cell 
extracts were prepared from LFB cell lines using M‐PER™ 
Mammalian Protein Extraction Reagent (Thermo Fisher 
Scientific) as previously reported (Bottega et al., 2018). 
Primary antibodies were used as follows: anti‐DDX11 
(Santa Cruz, sc‐271711, 1:500) and anti‐β‐actin (Santa Cruz, 
sc‐47778, 1:2000). Immuno‐reactivity was visualized using 
the Enhanced Chemiluminescent SuperSignal™ West Femto 
Maximum Sensitivity Substrate (Pierce).
2.4 | Bioinformatic analyses
The effect of the missense variant was evaluated by 
means of several prediction programs, such as Combined 
Annotation Dependent Depletion (CADD; http://cadd.
gs.washington.edu/home), Mutation Taster (http://www.
mutationtaster.org/), Mutation Assessor (http://mutatio-
nassessor.org/), and PolyPhen‐2 (http://genetics.bwh.
harvard.edu/pph2/). Multiple sequence alignments were 
generated with the Clustal Omega server (Sievers et al., 
2011) and manually modified to account for the position 
of the secondary structure elements. The following groups 
of residues were considered very similar and highlighted 
in yellow in Figure 3a: Glu/Asp, Arg/Lys, Val/Ile/Leu/
Met/Cys, Gly/Ala, Tyr/Phe/Trp, Ser/Thr/Pro, Asn/Gln. A 
three‐dimensional model was generated using the RaptorX 
Structure Prediction program (Källberg et al., 2012). The 
best template was found to be the 10 Å resolution CryoEM 
F I G U R E  1  Clinical and cellular 
features. (a) Typical dysmorphisms observed 
in Warsaw Breakage Syndrome patients: 
bilateral epicanthal folds, upslanting 
palpebral fissures, prominent nose and 
columella with hypoplastic alae nasi, 
small ears, and micrognathia. (b) Trunk 
image showing the café‐au‐lait spots. (c) 
Comparison of the mitomycin C (MMC) 
induced cell survival analysis in LFB cells 
from a wild‐type (WT), patients carrying 
the DDX1 mutations (II‐1 and II‐2) and a 
Fanconi anemia patient carrying mutations 
in FANCA gene (FA‐A). WBS patients 
shows an intermediate phenotype. (d) 
Karyotype analyses after MMC induction
a b 
c d 
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structure of human XPD, as found in the TFIIH com-
plex (PDB ID: 5IVW, chain W) with a p‐value 7.4e‐12. 
Although this complex was not determined at atomic 
resolution, the structure of XPD was built on the basis of 
homologous archaeal structures determined at high resolu-
tion. The picture of the DDX11 atomic model (Figure 3b) 
was generated using PyMOL (http://pymol.org/).
3 |  RESULTS
Two 5‐year‐old and 4‐year‐old sisters, born of noncon-
sanguineous healthy parents were referred to the Genetic 
Department because of hearing impairment. Both sisters 
had intra‐uterine growth retardation (IUGR); at birth (37 
gs) they were small for gestational age with weight, length, 
and head circumference of 2,230 g, 44.5 cm, 30.5 cm and 
1,820 g, 42 cm, 28 cm, respectively. During the dysmor-
phological evaluation the anthropometric values were 
under the 3° centile with a more pronounced microcephaly 
(−3.34 and −4.09 SD). They both showed sloping forehead 
with apparently narrow bifrontal diameter, prominent eyes 
with bilateral epicanthal folds, upslanting palpebral fis-
sures, prominent nose and columella with hypoplastic alae 
nasi, small ears, and micro/retrognathia. In the trunk and 
legs skin they showed several café‐au‐lait spots (Figure 
1a,b). Computed tomography of brain and magnetic reso-
nance imaging revealed a rather small and rounded cochlea. 
Both patients present a hearing loss that appears moderate 
(Pure tone audiometry: wave V elicitable down to 80 dB on 
the right ear and 70 dB on the left) in the older sister and 
profound (Pure tone audiometry: wave V undetectable) in 
the younger one. The IQ tests performed with the Wppsi‐
III scale showed a normal global cognitive IQ (92) with a 
homogeneous pattern (Verbal IQ: 100; Performance: 93) 
in the older sister and a borderline global cognitive IQ of 
75 (Verbal IQ: 69; Performance: 93) in the younger sister, 
which mostly affects her verbal ability, also considering 
the severe hearing loss of course.
The hand radiography revealed a mild bilateral short-
ening of the first metacarpal bone in the young sister as 
already reported for WABS patients (Eppley et al., 2017). 
Because of these features, a clinical WABS suspicion was 
hypothesized. As WABS cells are reported to show MMC 
sensitivity (van der Lelij et al., 2010), an MMC survival test 
was performed in lymphoblastoid cells from the two sisters 
comparing them to FA patient cells (compound heterozy-
gous for c.3660del and c.50dup of the FANCA gene). This 
revealed an intermediate sensitivity (Figure 1c) (Bottega 
et al., 2018). The karyotype analysis after MMC induction 
showed the typical railroad chromosomes (Figure 1d), sug-
gesting a diagnosis of WABS.
We therefore screened for mutations the DDX11 gene by 
Sanger sequencing and detected two variants (c.2507T > C; 
p.Leu836Pro and c.907_920del; p.Lys303Glufs*22) in both 
sisters (Figure 2a,b). Segregation analyses demonstrated the 
paternal and maternal origin of the missense variant and dele-
tion, respectively (Figure 2c). Both variants are not reported 
in pathogenicity and healthy control databases. Whereas the 
deletion of 14 nucleotides represents a clear deleterious vari-
ant that leads to frameshift and premature stop codon, the 
outcome of a substitution is generally unclear; p.Leu836Pro 
was thus investigated in order to determine its effect. It was 
predicted to be likely pathogenic according to the ACMG/
AMP guidelines and by all the pathogenicity prediction 
tools used (MutationTaster, score = 0.999, “Disease caus-
ing”; MutationAssessor, score = 3.6, “High”; PolyPhen‐2, 
score = 0.995, “Probably damaging”) except CADD 
(score = 17, “Neutral”).
Moreover, multiple sequence alignment among DDX11 
proteins and other FeS helicases show that the position of 
Leu836 is conserved among orthologs (Figure 3a).
F I G U R E  2  Patients’ mutations 
and DDX protein expression. (a) Sanger 
sequencing validation of c.2507T > C 
(p.Leu836Pro) and (b) c.907_920del 
(p.Lys303Glufs*22) DDX11 mutations. 
(c) Pedigree of the family. (d) Western 
blot analyses of WBS patients (II‐1 and 
II‐2) showing a partial expression (22% 
and 23%, respectively) of DDX protein 
compared to wild type. HSP90 was used as 
loading control and normalizator for protein 
quantification
a
GTGGAGAACCTGTGCATGAAG
c.2507T>C 
C
b 
c.907_920del  
GAGAAGCCAAAGAGGAGGAGGC
GAGGCAGGAGAAGCAGGCA
c 
c.907_920del / wt c.2507T>C / wt
c.907_920del / c.
2507T>C 
c.907_920del / c.
2507T>C 
I 
II 
DDX11 
HSP90 
1.0 0.22 0.23 
WT II-1 II-2 
d 
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Residue Leu836, in the context of the FeS helicases 
framework, is located within the HD2 catalytic domain, 
just before the helicase motif VI, that is relatively well 
conserved among different species (Figure 3a) (Sievers 
et al., 2011). Secondary structure predictions suggest 
that Leu836 is imbedded in an α‐helix structure that is 
not compatible with a proline substitution (Källberg et 
al., 2012). The Leu836Pro substitution would cause a sig-
nificant disruption in the protein structure (Figure 3b). 
Moreover, template‐based modeling of human DDX11 
suggests that this residue would sit in a critical position, at 
the interface between the homology domain 1 and 2 (HD1, 
HD2) and ARCH domains, and possibly close to the DNA 
binding region (Figure 3b) (Kuper, Wolski, Michels, & 
Kisker, 2012).
Finally, the DDX11 protein expression was investigated 
by western blot (Figure 1c) demonstrating a very low expres-
sion (22%) compared to the wild‐type (100%). This residual 
protein expression is more likely caused by the allele carry-
ing the c.2507T > C, as the p.Lys303Glufs*22 mutant form 
derived from the c.907_920del allele is not detectable and is 
probably degraded.
4 |  DISCUSSION
WABS is a recently described disease reported for the first 
time in 2010 by van der Lelij et al. (2010). It belongs to the 
group of cohesinopathies, which include WABS, Roberts 
syndromes (RBS), and Cornelia de Lange Syndrome (CdLS). 
WABS is considered a cohesinopathy since DDX11 muta-
tion are associated with premature sister chromatid separa-
tion (Banerji, Skibbens, & Iovine, 2017). WABS patients 
show a clinical overlap with RBS and CdLS, even if these 
two last conditions are characterized by a more severe phe-
notype including several malformations such as cochlear, 
palate, limb, heart, kidney, genital, and gastrointestinal de-
fects. The clinical picture of our two patients is similar to that 
previously described for other WABS, except for the cog-
nitive development delay and the metacarpal bone defects. 
Indeed, even though all the cases described so far show an 
intellectual disability associated with language impairment 
(Alkhunaizi et al., 2018), the intellectual performance of the 
two sisters was “normal” in the older and “borderline” in the 
younger, suggesting that, at least at present, their phenotype 
F I G U R E  3  DDX11 alignment and 3D 
structure. (a) Multiple sequence alignment 
of eukaryotic DDX11 with the other human 
FeS cluster helicases. Residues conserved 
in most DDX11 sequences are highlighted 
in yellow. The mutated L836 residue is 
shown in red and indicated by a star. The 
predicted secondary structure is shown on 
the top (rectangular blue bar for α‐helix and 
purple arrows for β‐strands). (b) A DDX11 
atomic model has been generated starting 
from XPD crystal structure (PDB ID: 4A15) 
with the ARCH domain in blue, HD1 and 
HD2 domains in two shades of green and 
the FeS cluster in orange. Unstructured 
regions/insertions in DDX11 are indicated in 
purple. The position of L836 is shown at the 
interface between the domains
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is mild. Nevertheless, considering the microcephaly and the 
young age, patients will be followed up to evaluate their 
performances.
Of note, abnormalities of the first metacarpal bone are in-
frequent and inconstant features in WABS families as well as 
in patients from the same family, as seen in our two patients.
Regarding the MMC breakage test, its use as a diagnos-
tic tool for WABS is controversial as the cytogenetic defects 
were not observed in all patients (Alkhunaizi et al., 2018; 
Bailey et al., 2015; Capo‐Chichi et al., 2013; Eppley et al., 
2017; van der Lelij et al., 2010). Although the MMC break-
age sensitivity was critical to diagnose our family, further 
investigation is needed to characterize the chromosomal in-
stability in WABS. However, it is necessary to emphasize that 
chromosomal instability assays are difficult to perform and 
not always reproducible among different laboratories.
The diagnostic suspicion was confirmed by the molecu-
lar diagnosis that allowed us to identify two novel variants 
of DDX11 (c.907_920del and c.2507T > C). Whereas the 
first one was considered deleterious leading to a prema-
ture stop codon (p. p.Lys303Glufs*22), we considered the 
second one (p.Leu836Pro) as pathogenic because it: (i) af-
fects a highly conserved amino acid among DDX11 orthol-
ogous; (ii) should cause a significant change in the protein 
structure; (iii) hits a critical residue located at the interface 
between the HD1, HD2, and ARCH domains which may be 
close to the DNA binding region; (iv) is associated with low 
DDX11 expression level in patients’ LFB, suggesting that 
the mutant protein is partially degraded or has a reduced 
half life. Consistently with our data, all missense mutations 
of DDX11 tested for their in‐vitro expression are expressed 
even if at low level (Alkhunaizi et al., 2018; Capo‐Chichi 
et al., 2013). Considering that the knockout of Ddx11 mice 
resulted in embryonic lethality at E10.5 (Inoue et al., 2007 
Jul), taken together, these data lead us to hypothesize that a 
complete loss‐of‐function of DDX11 gene is incompatible 
with life. As a consequence, only patients carrying at least 
one hypomorphic mutation in DDX11 exhibit the disease. 
Indeed, in most of the WABS families described so far (7 
out of 9) at least one allele could be regarded as potentially 
nondeleterious (missense/in‐frame 3nt deletion), since it is 
compatible with the production of a rather stable hypomor-
phic protein.
The exceptions consist in one family described 
by Alkhunaizi et al. (2018) in which the homozygous 
c.2638dupG is located in the C‐term of the protein, which 
could retain some functional activity, and in another family 
described in Bailey et al. (2015) whose splice site mutation 
(c.638 + 1G>A) in intron 5 was not investigated for a possi-
ble in‐frame product.
WABS is considered an ultra rare condition since, 
until now, only 14 patients from nine unrelated families 
are reported. In very rare autosomal recessive diseases 
the prevalence increases in consanguineous families with 
a consequent homozygous state of mutations. In WABS, 
only four families out of nine carry a homozygous mutation 
suggesting that this syndrome could be more frequent than 
expected and recalling the need to report new cases for its 
better characterization.
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